ST7 antibody (Middle Region)
Quick Overview for ST7 antibody (Middle Region) (ABIN954962)
Target
See all ST7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 176-205, Middle Region
-
Specificity
- This antibody reacts to ST7.
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human.
-
Purification
- Affinity chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 176-205 amino acids from the Central region of human ST7
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS, 0.09 % (W/V) sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- ST7 (Suppression of Tumorigenicity 7 (ST7))
-
Alternative Name
- ST7
-
Background
- The gene for this product maps to a region on chromosome 7 identified as an autism-susceptibility locus. Mutation screening of the entire coding region in autistic individuals failed to identify phenotype-specific variants, suggesting that coding mutations for this gene are unlikely to be involved in the etiology of autism. The function of this gene product has not been determined. Transcript variants encoding different isoforms of this protein have been described.Synonyms: DKFZp762O2113, FAM4A1, HELG, RAY1, SEN4, Suppressor of tumorigenicity 7 protein, TSG7
-
Molecular Weight
- 67166 Da
-
Gene ID
- 7982
-
NCBI Accession
- NP_060882
Target
-